Incidence and risk factors of recurrent venous thromboembolism after pulmonary embolism
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Hun-Gyu | - |
dc.contributor.author | Choi, Won-Il | - |
dc.contributor.author | Lee, Bora | - |
dc.contributor.author | Lee, Choong Won | - |
dc.date.accessioned | 2023-08-22T03:07:41Z | - |
dc.date.available | 2023-08-22T03:07:41Z | - |
dc.date.created | 2023-07-21 | - |
dc.date.issued | 2019-10 | - |
dc.identifier.issn | 1738-3536 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/189474 | - |
dc.description.abstract | Background: Information about the epidemiology of venous thromboembolism (VTE) recurrence in Korea is lacking. The purpose of this study was to investigate VTE cumulative recurrence rates and identify risk factors for VTE recurrence among Korean adults. Methods: A retrospective cohort study was conducted on adult patients (≥18 years) admitted to a university teaching hospital for pulmonary embolism (PE) from 2005 to 2013. The main outcome of interest was a recurrence of VTE. We used Cox proportional hazard regression analyses to calculate the relative risk of VTE recurrence. Results: Five-year cumulative incidence of recurrent VTE events was 21.5% (95% confidence interval [CI], 17.7–25.4) in all cases of PE; 17% after provoked and 27% after unprovoked PE. Multivariate analysis showed that body mass index (BMI) of ≥25 (hazard ratio [HR], 2.02; 95% CI, 1.17–3.46; p=0.01) and longer anticoagulation therapy duration (HR, 0.90; 95% CI, 0.84–0.96; p<0.01) were independently associated with risk of VTE recurrence. Risk factors not found to be statistically significant at the <0.05 level included history of VTE (HR, 1.81; 95% CI, 0.84–3.88; p=0.12), unprovoked PE (HR, 1.70; 95% CI, 0.89–3.25; p=0.10), symptomatic deep vein thrombosis (HR, 1.62; 95% CI, 0.89–2.94; p=0.10), and female sex (HR, 1.42; 95% CI, 0.78–2.55; p=0.24). We found that age, history of cancer, and other co-morbidities did not significantly affect the risk of VTE recurrence. Conclusion: Recurrence of VTE after PE is high. Patients with BMI ≥25 or reduced anticoagulation therapy duration have a higher risk of recurrent VTE. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean National Tuberculosis Associationknta@knta.or.kr | - |
dc.title | Incidence and risk factors of recurrent venous thromboembolism after pulmonary embolism | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Won-Il | - |
dc.identifier.doi | 10.4046/trd.2019.0019 | - |
dc.identifier.scopusid | 2-s2.0-85082313928 | - |
dc.identifier.wosid | 000489092800010 | - |
dc.identifier.bibliographicCitation | Tuberculosis and Respiratory Diseases, v.82, no.4, pp.341 - 347 | - |
dc.relation.isPartOf | Tuberculosis and Respiratory Diseases | - |
dc.citation.title | Tuberculosis and Respiratory Diseases | - |
dc.citation.volume | 82 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 341 | - |
dc.citation.endPage | 347 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.identifier.kciid | ART002513793 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.subject.keywordPlus | DEEP-VEIN THROMBOSIS | - |
dc.subject.keywordPlus | ORAL ANTICOAGULANT-THERAPY | - |
dc.subject.keywordPlus | POSTTHROMBOTIC SYNDROME | - |
dc.subject.keywordPlus | BLEEDING COMPLICATIONS | - |
dc.subject.keywordPlus | ANTITHROMBOTIC THERAPY | - |
dc.subject.keywordPlus | ASIAN PATIENTS | - |
dc.subject.keywordPlus | 1ST EPISODE | - |
dc.subject.keywordPlus | VTE | - |
dc.subject.keywordPlus | HYPERTENSION | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordAuthor | Pulmonary Embolism | - |
dc.subject.keywordAuthor | Recurrence | - |
dc.subject.keywordAuthor | Venous Thromboembolism | - |
dc.identifier.url | https://e-trd.org/journal/view.php?doi=10.4046/trd.2019.0019 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.